• Health & Medicine

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England. A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

9 February 2021

• Health & Medicine

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab. People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab.

30 January 2021

• Health & Medicine

Transforming optimism: finding new ways to treat rare cancers

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma. We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

27 January 2021

• Health & Medicine
• Science & Technology

Genetic changes in tumours may predict who will respond to immunotherapy

Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments.  Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments. 

27 January 2021

• Health & Medicine

NHS patients among first to access new CAR T cell therapy for lymphoma

Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy. Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.

20 January 2021

• Health & Medicine

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

13 November 2020

• Health & Medicine

Scientists develop next-generation immunotherapy now entering early phase clinical trials

Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system. Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.

9 November 2020

• Health & Medicine

Immunotherapy drug approved for head and neck cancer

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

26 October 2020

• Health & Medicine

Immunotherapy treatment recommended for advanced small cell lung cancer 

A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer. A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.

5 June 2020

• Health & Medicine

Immunotherapy for triple negative breast cancer approved for NHS in England 

Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer. Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.

26 May 2020

• Health & Medicine

Two skin cancer treatments get the green light for NHS Scotland

An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).  An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC). 

12 February 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020